SmallerStandardBiggerPrintRSS FeedFollow TVM Capital on TwitterSearch

News Release

06/19/2009

TVM Capital promotes Dr. Irena Melnikova to Principal

June 19, 2009, Boston, MA – Dr. Irena Melnikova has been promoted to Principal of the TVM Capital Life Science Team in Boston. She has been a valuable addition to the Boston office due diligence and investment capabilities since joining TVM Capital in 2008.

“Irena’s strong scientific knowledge has been a key asset in investment management and the evaluation of new investment opportunities,” said Dr. Helmut Schühsler, managing partner of TVM Capital. “We look forward to expanding her role with the TVM Capital life science portfolio as we make new investments.”

Prior to joining TVM Capital, Dr. Melnikova launched and produced “Future in Focus,” a series of syndicated reports for Leerink Swann and was a member of the biopharma investment banking team where she supported due diligence and opportunity assessment activities that resulted in public and private financings as well as M&A transactions.

Dr. Melnikova has held positions at Life Science Insights, a subsidiary of IDC, the leading technology market research company as a research manager and as a project leader at TransForm Pharmaceuticals (acquired by Johnson & Johnson) where she was responsible for running several programs including Engineered Tissue Constructs and Amyloidoses.

She holds a Ph. D. in Molecular Medicine/Molecular Biology from the University of Texas and an MS with Honors in Chemical Engineering from Russian University of Chemical Technology. In addition, Dr. Melnikova is a regular contributor to the “Analyst Couch” section of Nature Reviews in Drug Discovery magazine and is the co-inventor on a filed patent for methods for identifying conditions affecting a cell state.

Dr. Melnikova will be speaking at the Stem Cells USA & Regenerative Medicine Congress, in Washington, DC in November 2009 (http://www.terrapinn.com/2009/stemcellsusa/).


Press Contact
Monika Schlesinger
TVM Capital GmbH
Maximilianstr. 35, Eingang C
D- 80539 Munich, Germany
++49 (89) 998 992-0


Nancy Saucier
TVM Capital
101 Arch Street, Suite 1950
Boston, MA 02110, USA
+1 (617) 345 9320